Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Brennan
R S Bahn

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Thyroid hormones and illnessM D Brennan, R S Bahn
Thyroid : Official Journal of the American Thyroid Association|June 1, 1995
Nongoitrous (type I) amiodarone-associated thyrotoxicosis: evidence of follicular disruption in vitro and in vivoM D Brennan, D Z Erickson, J A Carney, et al.
International Archives of Allergy and Immunology|March 1, 1995
The fibroblast is the target cell in the connective tissue manifestations of Graves' diseaseR S Bahn
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 1, 1995
Assessment and management of the patient with Graves' ophthalmopathyR S Bahn
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 12, 2015
Current Insights into the Pathogenesis of Graves' OphthalmopathyR S Bahn
Journal of Endocrinological Investigation|May 29, 2004
TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathyR S Bahn
Endocrinology and Metabolism Clinics of North America|June 30, 2000
Understanding the immunology of Graves' ophthalmopathy. Is it an autoimmune disease?R S Bahn
Thyroid : Official Journal of the American Thyroid Association|June 12, 1998
Cytokines in thyroid eye disease: potential for anticytokine therapyR S Bahn
Clinical Pharmacology and Therapeutics|March 22, 2012
Autoimmunity and Graves' diseaseR S Bahn
Autoimmunity|January 1, 1997
Cytokines in the evolution of Graves' ophthalmopathyN Natt, R S Bahn
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Thyroid hormones and illnessM D Brennan, R S Bahn
Thyroid : Official Journal of the American Thyroid Association|June 1, 1995
Nongoitrous (type I) amiodarone-associated thyrotoxicosis: evidence of follicular disruption in vitro and in vivoM D Brennan, D Z Erickson, J A Carney, et al.
International Archives of Allergy and Immunology|March 1, 1995
The fibroblast is the target cell in the connective tissue manifestations of Graves' diseaseR S Bahn
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 1, 1995
Assessment and management of the patient with Graves' ophthalmopathyR S Bahn
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 12, 2015
Current Insights into the Pathogenesis of Graves' OphthalmopathyR S Bahn
Journal of Endocrinological Investigation|May 29, 2004
TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathyR S Bahn
Endocrinology and Metabolism Clinics of North America|June 30, 2000
Understanding the immunology of Graves' ophthalmopathy. Is it an autoimmune disease?R S Bahn
Thyroid : Official Journal of the American Thyroid Association|June 12, 1998
Cytokines in thyroid eye disease: potential for anticytokine therapyR S Bahn
Clinical Pharmacology and Therapeutics|March 22, 2012
Autoimmunity and Graves' diseaseR S Bahn
Autoimmunity|January 1, 1997
Cytokines in the evolution of Graves' ophthalmopathyN Natt, R S Bahn
Pageof 12